WWL0245
WWL0245 is a potent and seletive BRD4 PROTAC. WWL0245 selectively degrades BRD4 with sub-nanomolar DC50 (<1 nM) than BRD2/3 and PLK1 ( DC50>1 μM). WWL0245 shows excellent selective cytotoxicity in the BETi sensitive cancer cell lines, including AR-positive prostate cancer cell lines. WWL0245 is a promising drug candidate for AR-positive prostate cancer research and a valuable tool compound to study the biological function of BRD4.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2869057-11-2
- 分子式: C45H51N11O8
- 分子量:873.96
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
BRD4 1 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CWR22R | IC50 |
0.053 μM
Compound: 12a; WWL0245
|
Antiproliferative activity against AR-positive human 22Rv1 cells assessed as reduction in cell viability measured after 4 days by MTT assay
Antiproliferative activity against AR-positive human 22Rv1 cells assessed as reduction in cell viability measured after 4 days by MTT assay
|
[PMID: 34700270] |
| DU-145 | IC50 |
10 μM
Compound: 12a; WWL0245
|
Antiproliferative activity against AR-negative human castration resistant DU-145 cells assessed as reduction in cell viability measured after 4 days by MTT assay
Antiproliferative activity against AR-negative human castration resistant DU-145 cells assessed as reduction in cell viability measured after 4 days by MTT assay
|
[PMID: 34700270] |
| LNCaP | IC50 |
0.021 μM
Compound: 12a; WWL0245
|
Antiproliferative activity against AR-positive harmone sensitive human LNCaP cells assessed as reduction in cell viability measured after 4 days by MTT assay
Antiproliferative activity against AR-positive harmone sensitive human LNCaP cells assessed as reduction in cell viability measured after 4 days by MTT assay
|
[PMID: 34700270] |
| MV4-11 | IC50 |
0.003 μM
Compound: 12a; WWL0245
|
Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability measured after 4 days by MTT assay
Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability measured after 4 days by MTT assay
|
[PMID: 34700270] |
| PC-3 | IC50 |
2.435 μM
Compound: 12a; WWL0245
|
Antiproliferative activity against AR-negative human castration resistant PC-3 cells assessed as reduction in cell viability measured after 4 days by MTT assay
Antiproliferative activity against AR-negative human castration resistant PC-3 cells assessed as reduction in cell viability measured after 4 days by MTT assay
|
[PMID: 34700270] |
| VCaP | IC50 |
0.016 μM
Compound: 12a; WWL0245
|
Antiproliferative activity against AR-positive human VCaP cells assessed as reduction in cell viability measured after 4 days by MTT assay
Antiproliferative activity against AR-positive human VCaP cells assessed as reduction in cell viability measured after 4 days by MTT assay
|
[PMID: 34700270] |
WWL0245 (0-1 μM; 96h) suppresses the proliferation of AR-positive prostate cancer cells with IC50 values range from 0.0159 μM -10 μM. It shows greater antiproliferative activity to AR-positive cell lines VCaP, LNCaP, 22Rv1 with IC50 values of 0.016 μM, 0.021 μM, 0.053 μM, respectively[1].WWL0245 (1 μM; 24 hours) results in the downregulation of BRD4 and c-Myc in a time-dependent manner in LNCaP, 22Rv1, VCaP cell lines and results in the decrease of BRD4 level and c-Myc level in a concentration-dependent manner in 22Rv1 and VCaP cell with DC50 of sub-nanomolar. But WWL0245 could also downregulate BRD4 level in DU145 cells but has negligible effects in c-Myc level[1].WWL0245 (100 nM-1 μM; 24 hours) suppresses the transcription of AR-regulated genes (PSA, TMPRSS2, ERG, FKBP5, BMPR1B) at various degrees[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HL60, SU-DHL-6, RS4;11, JURKAT, A2780, MDA-MB-468, BT549, LNCaP, 22Rv1, and VCaP cells
-
Concentration:0 μM -10 μM
-
Incubation Time:96 h
-
Result:Inhibited HL60, SU-DHL-6, RS4;11, JURKAT, A2780, MDA-MB-468, BT549, LNCaP, 22Rv1, and VCaP growth with IC50 values of 0.0961, 0.0734, 0.0247, 0.5018, 0.0153, 0.2460, and 0.1732 μM, respcetively
[1].
-
Cell Line:Prostate cancer cell lines: LNCaP, 22Rv1, VCaP, DU145
-
Concentration:1 nM, 10 nM, 100 nM, 1000 nM, 10000 nM
-
Incubation Time:1 hour, 2 hours, 4 hours,12 hours, 24 hours,48 hours
-
Result:Resulted in the downregulation of BRD4 and c-Myc in a time/concentration-dependent manner in 22Rv1 and VCaP cells.
-
Cell Line:Prostate cancer: VCaP cell
-
Concentration:100 nM-1 μM
-
Incubation Time:24 h
-
Result:Suppressed the expression of AR-regulated genes in prostate cancer.
化学情報
-
CAS 番号 2869057-11-2
-
分子量 873.96
-
分子式 C45H51N11O8
-
SMILES
CC[C@@H](N(C1=N2)CC3CCCCC3)C4=NN=C(C)N4C1=CN=C2NC5=C(C=C(C=C5)C(NC6CCN(CC6)C(COC7=C8C(C(N(C9C(NC(CC9)=O)=O)C8=O)=O)=CC=C7)=O)=O)OC
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)